{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "16723093", "DateCompleted": {"Year": "2007", "Month": "07", "Day": "17"}, "DateRevised": {"Year": "2006", "Month": "05", "Day": "25"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1671-4083", "JournalIssue": {"Volume": "27", "Issue": "6", "PubDate": {"Year": "2006", "Month": "Jun"}}, "Title": "Acta pharmacologica Sinica", "ISOAbbreviation": "Acta Pharmacol Sin"}, "ArticleTitle": "Anti-inflammatory effect of amurensin H on asthma-like reaction induced by allergen in sensitized mice.", "Pagination": {"StartPage": "735", "EndPage": "740", "MedlinePgn": "735-40"}, "Abstract": {"AbstractText": ["To explore the anti-inflammatory effects of amurensin H on asthma-like reaction induced by allergen in sensitized mice.", "BALB/c mice were sensitized by ovalbumin (OVA, ip) on d 0 and d 14 and challenged with 1% OVA on d 18 to 22. Mice developed airway eosinophilia, mucus hypersecretion, and elevation in cytokine levels. Mice were administered amurensin H orally at the doses of 49, 70, or 100 mg/kg once every day from d 15 to the last day. Bronchoalveolar lavage fluid (BALF) were collected at 24 h and 48 h after the last OVA challenge. Levels of tumor necrosis factor-alpha (TNF-alpha), interleukin 4 (IL-4), interleukin 5 (IL-5), and interleukin 13 (IL-13) in BALF were measured using ELISA method. Differential cell counts of macrophages, lymphocytes, neutrophils and eosinophils were performed in 200 cells per slide (one slide per animal). Lung tissue sections of 6-mum thickness were stained with Mayer's hematoxylin and eosin for assessment of cell infiltration, mucus production, and tissue damage.", "Oral administration of amurensin H significantly inhibited OVA-induced increases in total cell counts, eosinophil counts, and TNF- alpha, IL-4, IL-5 and IL-13 levels in BALF. In addition, amuresin H dramatically decreased OVA-induced lung tissue damage and mucus production.", "Amurensin H may have therapeutic potential for the treatment of allergic airway inflammation."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China."}], "Identifier": [], "LastName": "Li", "ForeName": "Yi-Tang", "Initials": "YT"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yao", "ForeName": "Chun-Suo", "Initials": "CS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bai", "ForeName": "Jin-Ye", "Initials": "JY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lin", "ForeName": "Mao", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cheng", "ForeName": "Gui-Fang", "Initials": "GF"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Acta Pharmacol Sin", "NlmUniqueID": "100956087", "ISSNLinking": "1671-4083"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzofurans"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-13"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-5"}, {"RegistryNumber": "0", "NameOfSubstance": "Stilbenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "0", "NameOfSubstance": "amurensin H"}, {"RegistryNumber": "207137-56-2", "NameOfSubstance": "Interleukin-4"}, {"RegistryNumber": "9006-59-1", "NameOfSubstance": "Ovalbumin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism"], "DescriptorName": "Asthma"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Benzofurans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-13"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-4"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-5"}, {"QualifierName": ["pathology"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Ovalbumin"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Stilbenes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Necrosis Factor-alpha"}, {"QualifierName": ["chemistry"], "DescriptorName": "Vitis"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2006", "Month": "5", "Day": "26", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "7", "Day": "18", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "5", "Day": "26", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16723093", "10.1111/j.1745-7254.2006.00330.x"]}}], "PubmedBookArticle": []}